Medtronic (MDT) Reports In-Line Q2 EPS; Updates on FY15 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Medtronic (MDT) Reports In-Line Q2 EPS; Updates on FY15 Outlook

Medtronic (MDT) PT Raised to $83 at Piper Jaffray Following Q2 and Deal Progress

November 19, 2014 8:45 AM EST

Piper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Medtronic, Inc. (NYSE: MDT) to $83.00 (from $74.00) Wednesday following solid Q2 results and progress on the Covidien deal.

West commented, "
Medtronic reported F2Q15 results with revenues of $4.366B... More